After the close, Flexion Therapeutics (NASDAQ: FLXN) announced that on April 2, 2018, the Centers for Medicare Services (CMS) issued ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE